Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice

British Journal of Pharmacology

Volumn 117, Issue 5, 1996, Pages 914-918

  Dambisya, Yoswa M ^a   Lee, Tat Leang ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

L Arginine; L NAME; L NMMA; Naloxone precipitated withdrawal; Nitric oxide; Nitric oxide synthase inhibitors; Opioid dependence tolerance

Indexed keywords

ARGININE; ARGININE METHYL ESTER; MORPHINE; N(G) METHYLARGININE; NALOXONE; NITRIC OXIDE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; INCIDENCE; MALE; MORPHINE ADDICTION; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST; WITHDRAWAL SYNDROME;

EID: 0029868562     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15280.x     Document Type: Article

References (48)

1. ADAMS, M.L., KALICKI, J.M., MEYR, E.R. & CICERO, T.J. (1993). Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor. N-nitro-L-arginine methyl ester. Life Sci., 52, 245-249.
2. BABEY, A.-M, KOLESNIKOV, Y., CHENG, J., INTURRISI, C.E., TRIFILLETTI, R.R. & PASTERNAK, G.W. (1994). Nitric oxide and opioid tolerance. Neuropharmacology, 33, 1463-1470.
3. BHARGAVA, H.N. (1994). Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behaviour. Pharmacol. Rev., 46, 293-324.
4. BICKEL, W.K., STITZER, M.L., LIEBSON, I.A. & BIGELOW, G.E. (1988). Acute physical dependence in man: Effects of naloxone after brief exposure. J. Pharmacol. Exp. Ther., 244, 126-132.
5. BREDT, D.S. & SYNDER, S.H. (1989). Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. U.S.A., 86, 9030-9033.
6. CAPPENDIJK, S.L.T., DE VRIES, R. & DZOLJIC, M.R. (1993). Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Neurosci. Lett., 162, 97-100.
7. DAMBISYA, Y.M. & LEE, T.L. (1994). Antinociceptive effects of ketamine-opioid combinations in the mouse tail flick test. Methods Find. Exp. Clin. Pharmacol., 16, 179-184.
8. DAMBISYA, Y.M. & LEE, T.L. (1995a). Effects of nitric oxide synthase inhibitors on the induction and expression of opioid tolerance and dependence. Abstracts, 11th Scientific Meeting, Malaysian Society of Pharmacology and Physiology, p. 41.
9. G-monomethyl arginine (L-NMMA) and L-arginine on the antinociceptive effects of morphine in the mouse. Methods Find. Exp. Clin. Pharmacol., 17, (in press).
10. DAMBISYA, Y.M., WONG, C.L. & CHAN, K. (1990). Effects of ephedrine and phenylpropanolamine on the antinociceptive effects of morphine and codeine in mice. Arch. Int. Pharamacodyn., 308, 5-12.
11. DAMBISYA, Y.M., WONG, C.L. & CHAN, K. (1991). Effects of sympathomimetic agents on opiate analgesia, tolerance and dependence in mice. Methods Find. Exp. Clin. Pharmacol., 13, 239-248.
12. D'AMOUR, F.E. & SMITH, D.L. (1941). A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther., 72, 74-79.
13. EISENBERG, R.M (1982). Further studies on the acute dependence produced by opiate-naive rats. Life Sci., 31, 1531-1540.
14. G-nitro-L-arginine, attenuate analgesic tolerance to the muopioid morphine but not to the kappa opioids. Pain, 56, 69-75.
15. GARTHWAITE, J. (1991). Glutamate, nitric oxide and cell signalling in the nervous system. Trends Neurosci., 14, 60-67.
16. GOLDSTEIN, A. & SCHULZ, R. (1973). Morphine-tolerant longitudinal muscle strip from guinea pigileum. Br. J. Pharmacol., 48, 655-666.
17. HEISHMAN, S.J., STITZER, M.L., BIGELOW, G.E. & LEIBSON, I.A. (1989). Acute opioid physical dependence in post-addict humans: Naloxone dose-effects after brief morphine exposure. J. Pharmacol. Exp. Ther., 248, 127-134.
18. HO, I.K., LOH, H.H. & WAY, E.L. (1976). Pharmacological manipulation of gamma aminobutryic acid (GABA) in morphine analgesia, tolerance and physical dependence. Life Sci., 18, 1111-1124.
19. HO, I.K., LU, S.E., STOLMAN, S., LOH, H.H. & WAY, E.L. (1972). Influence of p-chlorophenylalanine on morphine tolerance and physical dependence and regional brain serotonin turnover studies in morphine tolerant-dependent mice. J. Pharmacol. Exp. Ther., 182, 155-165.
20. JOHNSON, S.M. & FLEMING, W.W. (1988). Mechanisms of cellular adaptive sensitivity changes: Application to opioid tolerance and dependence. Pharmacol. Rev., 41, 435-488.
21. KANNER, R.M. & FOLEY, K.M. (1981). Patterns of narcotic drug use in cancer pain clinic. Ann. N. Y. Acad. Sci., 362, 162-172.
22. KAWABATA, A., UMEDA, N. & TAKAGI, H. (1993). L-Arginine exerts a dual role in nociceptive processing in the brain: involvement of kyotorphin-Met-enkephalin pathway and NO-cyclic GMP pathway. Br. J. Pharmacol., 109, 73-79.
23. KIMES, A.S., VAUPEL, D.B. & LONDON, E.D. (1993). Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase. Psychopharmacology, 112, 521-524.
24. KITTO, K.F., HALEY, J.E. & WILCOX, G.L. (1992). Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci. Lett., 148, 1-5.
25. KNOWLES, R.G., PALACIOS, M., PALMER, R.M.J. & MONCADA, S. (1989). Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci. U.S.A., 86, 5159-5162.
26. KOLESNIKOV, Y.A., PICK, C.G., CISZEWSKA, G. & PASTERNAK, G.W. (1993). Blockade of tolerance to morphine but not to κ-opioids by a nitric oxide synthase inhibitor. Proc. Natl. Acad. Sci. U.S.A., 90, 5162-5166.
27. G-nitro-L-arginine prevents morphine tolerance. Eur. J. Pharmacol, 221, 399-400.
28. KOSERSKY, D.S., HARRIS, R.A. & HARRIS, L.D. (1974). Naloxone-precipitated jumping activity in mice following the acute administration of morphine. Eur. J. Pharmacol., 26, 122-124.
29. KOYUNCUOGLU, H., DIZDAR, Y., ARICIOGLU, F. & SAYIN, U. (1992). Effects of MK-801 on morphine physical dependence: attenuation and intensification. Pharmacol. Biochem. Behav., 43, 487-490.
30. MELLER, S.T. & GEBHART, G.F. (1993). Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain, 52, 127-136.
31. G-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br. J. Pharmacol., 102, 198-202.
32. MORRIS, R., SOUTHAM, E., BRAID, D.J. & GARTHWAITE, J. (1992). Nitric oxide may act as a messenger between dorsal root ganglia neurones and their satellite cells. Neurosci. Lett., 137, 29-32.
33. NEAL, B.S. & SPARBER, S.B. (1986). Mianserine attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine. J. Pharmacol. Exp. Ther., 236, 157-165.
34. RAHMAN, A.F.M.M., TAKAHASHI, M. & KANETO, H. (1993). Development of tolerance to morphine antinociception in mice treated with nociceptive stimulants. Jpn. J. Pharmacol., 63, 59-64.
35. RAHMAN, A.F.M.M., TAKAHASHI, M. & KANETO, H. (1994). Morphine dependence with or without tolerance in formalin-treated mice: Further evidence for dissociation. Jpn. J. Pharmacol., 66, 277-280.
36. RASMUSSEN, K., KRYSTAL, J.H. & AGHAJANIAN, G.K. (1991). Excitatory amino acids and morphine withdrawal: Differential effects of central and peripheral kynurenic acid administration. Psychopharmacology, 105, 508-512.
37. SAMANIN, R., CERVO, L., ROCHAT, C., POGGESI, E. & MENNINI, T. (1980). Reduction in the number of serotonin receptors in the brain stem in morphine dependent rats: Relationship to blockade of naloxone-precipitated jumping by serotonin agonists. Life Sci., 27, 1141-1147.
38. G-monomethyl-L-arginine and MK-801 on the abstinence syndrome in morphine-dependent mice. Brain Res., 642, 153-159.
39. THORAT, S.N., REDDY, P.L. & BHARGAVA, H.N. (1993). Evidence for the role of nitric oxide in k-opiate tolerance in mice. Brain Res., 621, 171-174.
40. TRUJILLO, K.A. & AKIL, H. (1991). Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science, 251, 85-87.
41. TSENG, L.F., LOH, H.H. & WEI, E.T. (1975). Effects of clonidine on morphine withdrawal signs in the rat. Eur. J. Pharmacol., 30, 93-99.
42. VACCARINO, A.L. & COURET, L.C. Jr. (1993). Formalin induced pain antagonizes the development of opiate dependence in the rat. Neurosci. Lett., 161, 195-198.
43. VACCARINO, A.L., MAREK, P., KEST, B., BEN-ELIYAHU, S., COURET, L.C. Jr., KAO, B. & LIEBESKIND, J.C. (1993). Morphine fails to produce tolerance when administered in the presence of formalin pain in rats. Brain Res., 627, 287-290.
44. WAY, E.L., LOH, H.H. & SHEN, F.H. (1968). Morphine tolerance, physical dependence and synthesis of brain 5-hydroxytryptamine. Science, 162, 1290-1292.
45. WAY, E.L., LOH, H.H. & SHEN, F.H. (1969). Simultaneous quantitative assessment of morphine tolerance and physical dependence. J. Pharmacol. Exp. Ther., 167, 1-8.
46. WONG, C.-L. & BENTLEY, G.A. (1978). Increased antagonist potency of naloxone caused by morphine pretreatment in mice. Eur. J. Pharmacol., 47, 415-422.
47. WÜSTER, M., SCHULZ, R. & HERZ, A. (1985). Opioid tolerance and dependence: Re-evaluating the unitary hypothesis. Trends Pharmacol. Sci., 6, 64-67.
48. YANO, I., NISHINO, H. & MURANO, T. (1979). Antagonism by naloxone of tolerance and dependence in mice given a single dose of morphine. Jpn. J. Pharmacol., 29, 357-366.